119 related articles for article (PubMed ID: 19682024)
21. Endocrine effects of valproate in adolescent girls with epilepsy.
de Vries L; Karasik A; Landau Z; Phillip M; Kiviti S; Goldberg-Stern H
Epilepsia; 2007 Mar; 48(3):470-7. PubMed ID: 17326798
[TBL] [Abstract][Full Text] [Related]
22. Fasting insulin and HOMA-index changes in patients treated with valproic acid.
Mania M; Javashvili L; Kasradze S; Okujava N
Georgian Med News; 2011 Oct; (199):48-52. PubMed ID: 22155806
[TBL] [Abstract][Full Text] [Related]
23. Childhood obesity and its health consequence in China.
Li Y; Yang X; Zhai F; Piao J; Zhao W; Zhang J; Ma G
Obes Rev; 2008 Mar; 9 Suppl 1():82-6. PubMed ID: 18307705
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of metabolic syndrome and obesity in renal transplanted Mexican children.
Ramirez-Cortes G; Fuentes-Velasco Y; García-Roca P; Guadarrama O; López M; Valverde-Rosas S; Velásquez-Jones L; Romero B; Toussaint G; Medeiros M
Pediatr Transplant; 2009 Aug; 13(5):579-84. PubMed ID: 18992053
[TBL] [Abstract][Full Text] [Related]
25. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
[TBL] [Abstract][Full Text] [Related]
26. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
Nguyen NT; Magno CP; Lane KT; Hinojosa MW; Lane JS
J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541
[TBL] [Abstract][Full Text] [Related]
27. Valproate-induced insulin resistance and obesity in children.
Verrotti A; la Torre R; Trotta D; Mohn A; Chiarelli F
Horm Res; 2009; 71(3):125-31. PubMed ID: 19188736
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
30. Maternal waist circumference and the prediction of children's metabolic syndrome.
Hirschler V; Roque MI; Calcagno ML; Gonzalez C; Aranda C
Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1205-10. PubMed ID: 18056567
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
[TBL] [Abstract][Full Text] [Related]
32. Circulating levels of allopregnanolone, a neuroactive steroid, and leptin during treatment with valproic acid in children with epilepsy.
Grosso S; Luisi S; Mostardini R; Matera M; Barlocco EG; Casarosa E; Balestri P; Petraglia F
Neuroendocrinology; 2011; 93(3):159-64. PubMed ID: 20980729
[TBL] [Abstract][Full Text] [Related]
33. Metabolic and endocrine effects of valproic acid chronic treatment.
Belcastro V; D'Egidio C; Striano P; Verrotti A
Epilepsy Res; 2013 Nov; 107(1-2):1-8. PubMed ID: 24076030
[TBL] [Abstract][Full Text] [Related]
34. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
35. Gender differences in obesity related cardiovascular risk factors in Spain.
Cordero A; León M; Andrés E; Ordoñez B; Laclaustra M; Grima A; Pascual I; Luengo E; Civeira F; Pocoví M; Alegría E; Casasnovas JA;
Prev Med; 2009 Feb; 48(2):134-9. PubMed ID: 19038283
[TBL] [Abstract][Full Text] [Related]
36. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy.
Geda G; Caksen H; Içağasioğlu D
Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250
[TBL] [Abstract][Full Text] [Related]
37. The role of ghrelin in weight gain and growth in epileptic children using valproate.
Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
[TBL] [Abstract][Full Text] [Related]
38. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
Poulain M; Doucet M; Drapeau V; Fournier G; Tremblay A; Poirier P; Maltais F
Chron Respir Dis; 2008; 5(1):35-41. PubMed ID: 18303100
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine.
Rakitin A; Kõks S; Haldre S
Seizure; 2016 May; 38():11-6. PubMed ID: 27061880
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of metabolic syndrome in obese Turkish children and adolescents.
Atabek ME; Pirgon O; Kurtoglu S
Diabetes Res Clin Pract; 2006 Jun; 72(3):315-21. PubMed ID: 16325296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
